Adverum Biotechnologies Inc (NASDAQ:ADVM)
| 1.60 Delayed Data As of Sep 25 |  -0.08 / -4.76%Today’s Change | 0.53 Today|||52-Week Range 2.34 | +176.10% Year-to-Date |
Latest ADVM News | Press Releases
No recent news for Adverum Biotechnologies Inc.
Today’s Trading
| Previous close | 1.68 |
| Today’s open | 1.61 |
| Day’s range | 1.57 - 1.65 |
| Volume | 184,323 |
| Average volume (3 months) | 451,760 |
| Market cap | $168.7M |
Data as of 3:59pm ET, 09/25/2023
Growth & Valuation
| Earnings growth (last year) | -4.88% |
| Earnings growth (this year) | +22.94% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.92 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EBSEmergent BioSolution... | +0.00 | +0.16% |
| APLTApplied Therapeutics... | -0.65 | -24.07% |
| XFORX4 Pharmaceuticals I... | +0.01 | +0.96% |
| MLLCFMolecular Partners A... | 0.00 | 0.00% |
Data as of 4:00pm ET, 09/25/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$0.31 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$154.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
